| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Domagrozumab Basic information |
| Product Name: | Domagrozumab | | Synonyms: | Domagrozumab;Research Grade Domagrozumab(DHA30603);Research Grade Domagrozumab;Domagrozumab (anti-GDF8) | | CAS: | 1629605-31-7 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Domagrozumab Structure]() |
| | Domagrozumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Domagrozumab Usage And Synthesis |
| Uses | Domagrozumab is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab induces muscle anabolic activity. Domagrozumab can be used in research of duchenne muscular dystrophy (DMD)[1]. | | in vivo | Domagrozumab (PF-06252616; 10 and 30 mg/kg; i.v.) increases myostatin levels in a dose-dependent manner and induces skeletal muscle hypertrophy in cynomolgus monkeys[1]. | | References | [1] St Andre M, et, al. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys. Skelet Muscle. 2017 Nov 9;7(1):25. DOI:10.1186/s13395-017-0141-y |
| | Domagrozumab Preparation Products And Raw materials |
|